{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T21:00:59Z","timestamp":1760043659680},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,7,1]],"date-time":"2002-07-01T00:00:00Z","timestamp":1025481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2002,7]]},"DOI":"10.1016\/s0010-7824(02)00318-9","type":"journal-article","created":{"date-parts":[[2002,10,8]],"date-time":"2002-10-08T11:17:01Z","timestamp":1034075821000},"page":"47-56","source":"Crossref","is-referenced-by-count":13,"title":["Evaluation of interaction potential of certain concurrently administered drugs with pharmacological and pharmacokinetic profile of centchroman in rats"],"prefix":"10.1016","volume":"66","author":[{"given":"M.","family":"Khurana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.K.","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.P.","family":"Kamboj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.C.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S0010-7824(02)00318-9_BIB1","first-page":"727","article-title":"New synthesis of cis- and trans-3-phenyl-4-[4-(\u03b2-pyrolidinoethoxy) phenyl]-7-methoxy chromans","volume":"9","author":"Ray","year":"1971","journal-title":"Indian J Chem"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1021\/jm00224a014","article-title":"Antifertility agents. 12. Structure activity relationship of 3,4- diphenyl chromenes and chromans","volume":"19","author":"Ray","year":"1976","journal-title":"J Med Chem"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB3","first-page":"103","article-title":"Antifertility activity of 3\u20134-trans-2,2-dimethyl-3-phenyl-4-[4-(\u03b2-pyrolidinoethoxy)phenyl]-7-methoxychromans","volume":"9","author":"Kamboj","year":"1971","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB4","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/med.1011","article-title":"Centchroman, a selective estrogen receptor modulator, as a contraceptive and for the management of hormone-related clinical disorders","volume":"21","author":"Singh","year":"2001","journal-title":"Med Res Rev"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1530\/jrf.0.0760317","article-title":"Effect of centchroman on tubal transport and pre-implantation embryonic developments in rats","volume":"76","author":"Singh","year":"1986","journal-title":"J Reprod Fertil"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB6","first-page":"444","article-title":"Fetal resorption in rats treated with an antiestrogen in relation to luteal phase nidatory estrogen secretion","volume":"126","author":"Singh","year":"1992","journal-title":"Acta Endocr"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB7","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0010-7824(95)00103-H","article-title":"Time related effects of a triphenylethylene antiestrogen on estrogen induced changes in uterine weight, estrogen receptors, and endometrial sensitivity in immature rats","volume":"51","author":"Trivedi","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0010-7824(96)00197-7","article-title":"Inhibition of progesterone induced development of giant mitochondria in uterine glandular epithelial cells by an antiestrogen in rat","volume":"54","author":"Chauhan","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1530\/jrf.0.1000367","article-title":"Duration of anti-implantation action of a triphenylethylene antiestrogen centchroman in adult female rats","volume":"100","author":"Singh","year":"1994","journal-title":"J Reprod Fertil"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.0.1350107","article-title":"Correlation of pinopod development on uterine luminal epithelial surface with hormonal events and endometrial sensitivity in rat","volume":"135","author":"Singh","year":"1996","journal-title":"Eur J Endocr"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0960-0760(96)00102-1","article-title":"Uterine estradiol and progesterone receptor concentration, activities of certain antioxidant enzymes and dehydrogenases and histoarchitecture in relation to time of secretion of nidatory estrogen and high endometrial sensitivity in rat","volume":"59","author":"Singh","year":"1996","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0010-7824(98)00055-9","article-title":"Uterine luminal epithelial alkaline phosphatase activity and pinopod development in relation to endometrial sensitivity in rat","volume":"58","author":"Bansode","year":"1998","journal-title":"Contraception"},{"year":"1988","first-page":"439","series-title":"Pharmacology for health in Asia","key":"10.1016\/S0010-7824(02)00318-9_BIB13"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB14","series-title":"Hormone antagonists for fertility regulation","first-page":"223","article-title":"Clinical evaluation of centchroman","author":"Nityanand","year":"1988"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB15","first-page":"227","article-title":"Centchroman","volume":"28","author":"Kamboj","year":"1992","journal-title":"Drugs of Today"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB16","first-page":"1141","article-title":"Biological profile of centchroman","volume":"15","author":"Kamboj","year":"1977","journal-title":"Indian J Exp Biol"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB17","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/ijc.2910430506","article-title":"Centchroman","volume":"43","author":"Misra","year":"1989","journal-title":"Int J Cancer"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB18","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0010-7824(01)00257-8","article-title":"Interaction with anti-implantation and estrogen antagonistic activities of dl-ormeloxifene, a selective estrogen receptor modulator, by tetracycline in female Sprague-Dawley rats","volume":"64","author":"Gosh","year":"2001","journal-title":"Contraception"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB19","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man","volume":"50","author":"Freireich","year":"1966","journal-title":"Cancer Chemother Rept"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB20","first-page":"216","article-title":"Local absorption kinetics into the portal system using the portal venous concentration difference after an oral dose of diclofenac in the awakening rat","volume":"24","author":"Tabata","year":"1996","journal-title":"Drug Metab Dispos"},{"year":"1980","first-page":"127","series-title":"Waynforth HB","key":"10.1016\/S0010-7824(02)00318-9_BIB21"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB22","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-4347(94)00197-9","article-title":"Simultaneous liquid chromatographic determination of centchroman and its 7-demethylated metabolite in serum and milk","volume":"658","author":"Lal","year":"1994","journal-title":"J Chrom B"},{"year":"1997","first-page":"148","series-title":"Pharmaceutical statistics","key":"10.1016\/S0010-7824(02)00318-9_BIB23"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB24","first-page":"148","article-title":"Tissue distribution and pharmacokinetics of centchroman, a new nonsteroidal post-coital contraceptive agent and its 7-desmethyl metabolite in female rats after a single oral dose","volume":"24","author":"Paliwal","year":"1996","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB25","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/BF01061761","article-title":"The influence of variable gastric emptying and intestinal ransit rates on the plasma level curve of cimetidine","volume":"15","author":"Oberle","year":"1987","journal-title":"J Pharmacokin Biopharm"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB26","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/clpt.1983.60","article-title":"Ranitidine bioavailability and kinetics in normal male subjects","volume":"33","author":"Garg","year":"1983","journal-title":"Clin Pharmaol Ther"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB27","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF00630286","article-title":"Pharmacokinetics of furosemide in man after intravenous and oral administration","volume":"26","author":"Hammarlund","year":"1984","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/clpt.1981.180","article-title":"Penicillamine pharmacokinetics in normal subjects","volume":"30","author":"Bergstron","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB29","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/(SICI)1099-081X(199708)18:6<543::AID-BDD52>3.0.CO;2-F","article-title":"Pharmacokinetics and multiple peaking of acebutolol enantiomers in rats","volume":"18","author":"Piquette-Miller","year":"1977","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB30","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF01066319","article-title":"A double peak phenomenon in the pharmacokinetics of veralipride after oral administration","volume":"15","author":"Plusquellec","year":"1987","journal-title":"J Pharmacokin Biopharm"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB31","first-page":"855","article-title":"A double peak phenomenon in the pharmacokinetics of alprazolam after oral administration","volume":"27","author":"Wang","year":"1999","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB32","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/jps.2600750713","article-title":"Discontinuous oral absorption of cimetroprium bromide, a new antispasmodic drug","volume":"75","author":"Imbimbo","year":"1986","journal-title":"J Pharm Sci"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB33","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jps.2600690408","article-title":"Pharmacokinetics and bioavailability of cimetidine in humans","volume":"69","author":"Veng-Pedersen","year":"1980","journal-title":"J Pharm Sci"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jps.2600700105","article-title":"Pharmacokinetic analysis by linear system approach. I","volume":"70","author":"Veng-Pedersen","year":"1981","journal-title":"J Pharm Sci"},{"year":"1996","first-page":"327","series-title":"The Merck Index. Centchroman (No. 2018)","key":"10.1016\/S0010-7824(02)00318-9_BIB35"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB36","series-title":"The theory and practice of industrial pharmacy","first-page":"221","article-title":"Biopharmaceutics","author":"Kwan","year":"1987"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB37","first-page":"67","article-title":"Further studies using carbamate esters as model compounds to investigate the role of lipophilicity in the gastrointestinal absorption of foreign compounds","volume":"195","author":"Houston","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB38","first-page":"31","article-title":"Centchroman","volume":"2","author":"Ratna","year":"1994","journal-title":"J Basic Appl Med"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB39","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1023\/A:1018943613122","article-title":"Physiological parameters in laboratory animals and humans","volume":"10","author":"Davies","year":"1993","journal-title":"Pharm Res"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB40","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1211\/0022357991773014","article-title":"Effect of caffeine on ibuprofen-induced gastric mucosal damage in rats","volume":"51","author":"Koyama","year":"1999","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB41","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1159\/000171523","article-title":"Nonsteroidal anti-inflammatory drugs","volume":"13","author":"Scarpignato","year":"1995","journal-title":"Diges Dis"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB42","first-page":"171","article-title":"A tuberculosis survey based on symptoms questioning and sputum examination","volume":"44","author":"Gopi","year":"1997","journal-title":"Indian J Tubercul"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB43","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2165\/00003088-199222010-00005","article-title":"Pharmacokinetic drug interactions with rifampicin","volume":"27","author":"Venkatesan","year":"1992","journal-title":"Clin Pharmacokin"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0009-9236(96)90018-1","article-title":"Rifampicin drastically reduces plasma concentration and effect of oral midazolam","volume":"59","author":"Backman","year":"1997","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB45","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.144.8.1667","article-title":"Rifampicin drug interactions","volume":"144","author":"Baciewicz","year":"1984","journal-title":"Arch Intl Med"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB46","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1001\/jama.236.12.1382","article-title":"Rifampin, oral contraceptives, and pregnancy","volume":"236","author":"Skolnick","year":"1976","journal-title":"JAMA"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00563105","article-title":"Effect of rifampicin on norethistrone pharmacokinetics","volume":"15","author":"Back","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB48","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0010-7824(80)90125-0","article-title":"The effect of rifampicin on the pharmacokinetics of ethynylestradiol in women","volume":"21","author":"Back","year":"1980","journal-title":"Contraception"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0163-7258(90)90019-X","article-title":"Enzyme induction and inhibition","volume":"48","author":"Berry","year":"1990","journal-title":"Pharmac Ther"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB50","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2710.1998.00086.x","article-title":"Clinically important pharmacokinetic drug-drug interactions","volume":"23","author":"Tanaka","year":"1998","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB51","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/ddr.430070208","article-title":"Centchroman","volume":"7","author":"Ratna","year":"1987","journal-title":"Drug Dev Res"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB52","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1021\/jm00358a026","article-title":"Antifertility agents. 38. Effect of side chain and its position on the activity of 3,4-diarylchromans","volume":"26","author":"Salman","year":"1983","journal-title":"J Med Chem"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB53","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jac\/37.6.1111","article-title":"Inducing properties of rifampicin and rifabutin for selected enzyme activities of the cytochrome P-450 and UDP-glucuronosyltransferase superfamilies in female rat liver","volume":"37","author":"Oesch","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB54","first-page":"1","article-title":"Role of pharmacokinetics and metabolism in drug discovery and development","volume":"49","author":"Lin","year":"1997","journal-title":"Pharmacol Rev"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-8981(99)00143-6","article-title":"Hepatic drug metabolism enzyme induction and serum triacylglycerol elevation in rats treated with chlordiazepoxide, griseofulvin, rifampicin, and phenytoin","volume":"289","author":"Olatunde","year":"1999","journal-title":"Clin Chem Acta"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB56","first-page":"35","article-title":"Influence of the combined chemotherapeutic drug tuboprim on drug metabolism","volume":"14","author":"Mitcheva","year":"1988","journal-title":"Acta Physiol Pharmacol Bulg"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB57","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2165\/00003495-198733010-00002","article-title":"Haloperidol decanoate","volume":"33","author":"Beresford","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB58","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0010-7824(99)00009-8","article-title":"Interaction between broad-spectrum antibiotics and the combined oral contraceptive pill","volume":"59","author":"Weaver","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/S0010-7824(02)00318-9_BIB59","doi-asserted-by":"crossref","first-page":"309","DOI":"10.2165\/00003088-199936050-00001","article-title":"Interactions between oral contraceptives and antifungals\/antibacterials. Is contraceptive failure the result?","volume":"36","author":"Weisberg","year":"1999","journal-title":"Clin Pharmacokinet"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782402003189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782402003189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,10]],"date-time":"2019-04-10T14:27:52Z","timestamp":1554906472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782402003189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,7]]}},"alternative-id":["S0010782402003189"],"URL":"https:\/\/doi.org\/10.1016\/s0010-7824(02)00318-9","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2002,7]]}}}